Clinical Trial Update: Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of montelukast in non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Tanta University | Conditions: Non Alcoholic Steatohepatitis | Phase 4 | Status: COMPLETED